230 related articles for article (PubMed ID: 32720600)
1. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and Clinicopathological Significance of Long Noncoding RNA GHET1 in Human Solid Tumors: a Meta-Analysis.
Zeng L; Yang M; Gao D; Li N
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658414
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA GHET1 in human cancer.
Li J; Jiang X; Li Z; Huang L; Zhou Y; Liu Y; Cui Y
Clin Chim Acta; 2019 Jan; 488():111-115. PubMed ID: 30399371
[TBL] [Abstract][Full Text] [Related]
7. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Expression of Gastric Carcinoma High Expressed Transcript 1 is a Diagnostic and Prognostic Biomarker in Human Cancer.
Wang H; Meng F; Dong S
J Natl Med Assoc; 2020 Dec; 112(6):602-612. PubMed ID: 32653201
[TBL] [Abstract][Full Text] [Related]
9. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
Zhang Q; Zhang Y; Wang Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta-analysis.
Liu W; Wang QP; Guo J
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 30910838
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis.
Wang D; Zhang H; Fang X; Zhang X; Liu H
Cancer Cell Int; 2020; 20():109. PubMed ID: 32280301
[TBL] [Abstract][Full Text] [Related]
15. The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis.
Song J; Chen X; Tian Q; Lun L; Wang Q; Wang H; Li X; Liu Z; Tian L; Jing X; Zhang Y; Tian R
Dis Markers; 2019; 2019():5824190. PubMed ID: 31885739
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Prognostic Value of Gastric Carcinoma Highly Expressed Transcript 1 in Cancer: A Meta-Analysis.
Zhou X; Fan Y; He Y; Mou A; Wang F; Liu Y; Wu Z
J Oncol; 2020; 2020():6341093. PubMed ID: 32908508
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
